Russian Foreign Ministry: OPCW not rushing to investigate chemical incident in SyriaRussian Politics & Diplomacy May 25, 21:28
Russia’s legendary barque Kruzenshtern calls at Belgian portSociety & Culture May 25, 20:26
OPEC and non-OPEC countries to develop cooperation outside Vienna agreementBusiness & Economy May 25, 19:44
Russia squared-off with Western media blitz to smear World Cup preparationsSport May 25, 19:35
NATO seeks to continue and expand dialogue with RussiaWorld May 25, 19:01
WADA offers pole vaulter Isinbayeva post of ambassador for clean sports in Russia — sourceSport May 25, 18:57
Lavrov keeps close eye on situation with jailed Russian pilot in USRussian Politics & Diplomacy May 25, 18:51
Belkomur rail project brings new opportunities to Russia’s Arctic regionsBusiness & Economy May 25, 18:46
Russia to build first helicopter carrier by 2022Military & Defense May 25, 17:41
MOSCOW, November 21. /ITAR-TASS/. The Russian Health Ministry has expressed concern over a big number of pharmacies in Russia, which provokes price dumping policies and lowers pharmacy quality standards, Health Minister Veronika Skvortsova told the Presidium of the Russian government on Thursday.
The Russian pharmacy market has a huge number of economic entities running the production and distribution sectors. A total of 550 organizations and a thousand foreign pharmacies have licenses for medicine production and deliveries, Skvortsova said with reference to the Single License Register of the Russian Ministry of Industry and Trade.
In Russia, there is one pharmacy per every 1,450 people, in the United States - one pharmacy per every 4,500 people and in Germany - one pharmacy per 3,900 people, she said. There is a surplus number of pharmacies in Russia; the quality of pharmacy services is worsening; the share of pharmacies capable to produce medicines or which have the necessary conditions for the storage of medicines and narcotic-containing stuff has been declining, Skvortsova said.
Creation of vertically integrated structures and large pharmacy networks hinders the development of a competitive environment, provokes price dumping and creates problems for producers of medicines, Skvortsova said.